Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: Pharmacogenet Genomics. 2018 Feb;28(2):49–55. doi: 10.1097/FPC.0000000000000318

Table 1.

Characteristics of genotyped patients in S0221

Patient
Characteristics
With genetic and phenotypic
information available (N=1853)
After genomic and
phenotypic quality
control (N=1408)
>=grade 3
(N=215)
<grade 3
(N=1638)
>= grade 3
(N=178)
< grade 3
(N=1230)
Arm
1 44 (13.3) 287 (86.7) 37 (14.7) 214 (85.3)
2 56 (15.6) 302 (84.4) 47 (18.3) 210 (81.7)
3 31 (8.2) 349 (91.8) 22 (7.9) 255 (92.1)
4 23(6.6) 327 (93.4) 20 (7.4) 249 (92.6)
5 38 (17.9) 174 (82.0) 32 (18.1) 145 (81.9)
6 23 (10.4) 199 (89.6) 20 (11.3) 157 (88.7)
Self-reported race*
White, not Hispanic 155 (10.5) 1319 (89.5) 147 (11.6) 1122 (88.4)
White, Hispanic 11 (10.6) 93 (89.4) 0 0
Black, not Hispanic 33 (19.8) 134 (80.2) 31 (22.3) 108 (77.7)
Black, Hispanic 1 (33.3) 2 (66.6) 0 0
Asian 10 (14.7) 58 (85.3) 0 0
Native 1 (6.7) 14 (93.3) 0 0
Pacific Islander 3 (37.5) 5 (62.5) 0 0
Race unknown 2 (25) 6 (75) 0 0
Mean BMI (sd) 30 (7.0) 31.4 (7.2) 32.71 (7.6) 30.7 (7.4)
Mean Age (sd) 50.8 (10.7) 53.1 (9.7) 53.1 (9.7) 50.1 (10.3)
*

race groups do not sum to total due to small overlaps (<2) across groups